Adiponectin, an adipocyte-derived protein
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
15544426
PII: 600
Knihovny.cz E-resources
- MeSH
- Adiponectin biosynthesis chemistry physiology MeSH
- Anti-Inflammatory Agents, Non-Steroidal metabolism MeSH
- Atherosclerosis metabolism prevention & control MeSH
- Hypoglycemic Agents metabolism MeSH
- Insulin Resistance physiology MeSH
- Humans MeSH
- Adipocytes metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Adiponectin MeSH
- Anti-Inflammatory Agents, Non-Steroidal MeSH
- Hypoglycemic Agents MeSH
Adipose tissue is a hormonally active tissue, producing adipocytokines which may influence activity of other tissues. Adiponectin, abundantly present in the plasma increases insulin sensitivity by stimulating fatty acid oxidation, decreases plasma triglycerides and improves glucose metabolism. Adiponectin levels are inversely related to the degree of adiposity. Anorexia nervosa and type 1 diabetes are associated with increased plasma adiponectin levels and higher insulin sensitivity. Decreased plasma adiponectin levels were reported in insulin-resistant states, such as obesity and type 2 diabetes and in patients with coronary artery disease. Activity of adiponectin is associated with leptin, resistin and with steroid and thyroid hormones, glucocorticoids, NO and others. Adiponectin suppresses expression of extracellular matrix adhesive proteins in endothelial cells and atherosclerosis potentiating cytokines. Anti-atherogenic and anti-inflammatory properties of adiponectin and the ability to stimulate insulin sensitivity have made adiponectin an important object for physiological and pathophysiological studies with the aim of potential therapeutic applications.
Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R)